{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:50:51Z","timestamp":1784152251451,"version":"3.55.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    We present a 34-year-old woman diagnosed with primary mucinous adenocarcinoma of the bladder, confirmed after transurethral resection. Two years postinitial diagnosis, despite chemotherapy, she developed pulmonary and skeletal metastases, leading to progressive symptoms including cough, hemoptysis and refractory bone pain. She was evaluated via\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-FAPI-46 scintigraphy, which showed significant uptake in metastatic lesions, suggesting suitability for radio-ligand therapy. However, the patient\u2019s condition deteriorated rapidly, and she passed away before treatment could be initiated. This case underscores the sensitivity of FAPI-targeted imaging in mucinous adenocarcinoma of the bladder and highlights the need for further investigation into its therapeutic applications.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005933","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T06:00:21Z","timestamp":1747116021000},"page":"e55-e56","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Favorable 99mTc-FAPI-46 Uptake in Primary Mucinous Adenocarcinoma of the Bladder"],"prefix":"10.1097","volume":"51","author":[{"given":"Nasrin","family":"Raeisi","sequence":"first","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Saber Tanha","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Khooei","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naime","family":"Ataei","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atena","family":"Aghaee","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"R1-20251210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s13193-019-01028-y","article-title":"Primary mucinous adenocarcinoma of the bladder: case report and review of literature","volume":"11","author":"Vijayakumar","year":"2020","journal-title":"Indian J Surg Oncol"},{"key":"R2-20251210","first-page":"221","article-title":"Bladder mucinous adenocarcinoma as a diagnostic challenge: a case report","volume":"42","author":"Maja","year":"2022","journal-title":"Pan Afr Med J Afr Field Epidemiol Net"},{"key":"R3-20251210","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2967\/jnumed.123.265471","article-title":"Evaluation of the diagnostic accuracy of FAPI PET\/CT in oncologic studies: systematic review and metaanalysis","volume":"64","author":"Wass","year":"2023","journal-title":"J Nucl Med"},{"key":"R4-20251210","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/RLU.0000000000003489","article-title":"Fibroblast activation protein inhibitor PET\/CT","volume":"46","author":"Sharma","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R5-20251210","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/RLU.0000000000003810","article-title":"Feasibility and therapeutic potential of 177Lu\u2013fibroblast activation protein inhibitor\u201346 for patients with relapsed or refractory cancers","volume":"46","author":"Assadi","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R6-20251210","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/RLU.0000000000003667","article-title":"Safety of fibroblast activation protein\u2013targeted radionuclide therapy by a low-dose dosimetric approach using 177Lu-FAPI04","volume":"46","author":"Kuyumcu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R7-20251210","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/RLU.0000000000003842","article-title":"Two tumors, one target","volume":"46","author":"Rathke","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R8-20251210","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1097\/RLU.0000000000005554","article-title":"Utilizing 99mTc-FAPI-46 SPECT\/CT in detection of peritoneal carcinomatosis in gastric poorly differentiated adenocarcinoma","volume":"50","author":"Raeisi","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R9-20251210","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1097\/RLU.0000000000005522","article-title":"99mTc-PSMA and 99mTc-FAPI-46 uptake in pulmonary lymphangitic carcinomatosis","volume":"49","author":"Raeisi","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R10-20251210","doi-asserted-by":"crossref","first-page":"e230195","DOI":"10.1148\/rycan.230195","article-title":"Assessing the value of 68 Ga-FAPI PET\/CT in gastric mucinous adenocarcinoma or signet ring cell carcinoma","volume":"6","author":"Sun","year":"2024","journal-title":"Radiol Imaging Cancer"},{"key":"R11-20251210","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/RLU.0000000000004641","article-title":"Role of 68Ga-FAPI PET\/CT in assessing hepatobiliary malignancies","volume":"48","author":"Rajaraman","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R12-20251210","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1097\/RLU.0000000000004652","article-title":"68Ga-FAPI PET\/CT provides a clear picture of a klatskin tumor that 18F-FDG PET\/CT missed","volume":"48","author":"Al-Ibraheem","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:01:22Z","timestamp":1765371682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005933","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"2025-01-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}